The increase in CD69+ B cells corresponded with a tremendous rise in the absolute proportion of B220+CD95+GL7+ GC B cells among all B220+ cells in tumor-bearing mice in lymph nodes and spleen throughout the observation period. This evidence concerns the gene CD69 and neoplasm.